As part of the National Institute for Health and Clinical Excellence (NICE) single technology appraisal (STA) process, the Evidence Review Group (ERG) produced a report to comment on the clinical and cost effectiveness of golimumab (Simponi<Superscript>®</Superscript>, Merck Sharp & Dohme) for the treatment of ankylosing...</superscript>